UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032353
Receipt number R000036901
Scientific Title A prospective registry of physical and psychological functional status after surgical or transcatheter aortic valve replacement in patients with aortic valve stenosis.
Date of disclosure of the study information 2018/04/24
Last modified on 2023/06/20 19:02:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A prospective registry of physical and psychological functional status after surgical or transcatheter aortic valve replacement in patients with aortic valve stenosis.

Acronym

Registry of physical and psychological functional status after SAVR or TAVI.

Scientific Title

A prospective registry of physical and psychological functional status after surgical or transcatheter aortic valve replacement in patients with aortic valve stenosis.

Scientific Title:Acronym

Registry of physical and psychological functional status after SAVR or TAVI.

Region

Japan


Condition

Condition

Aortic valve stenosis

Classification by specialty

Cardiology Cardiovascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate physical and psychological functional status at before and after SAVR or TAVI, and to find out which pre procedural markers predict these recovery.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Ambulation status at a week, 1, 6 and 12 months after procedure. Ambulation status is evaluated with 6-min walk test.

Key secondary outcomes

Cumulative survival rate after procedure.
Re-admission after procedure.
Physical function at a week, 1, 6 and 12 months after procedure.
Mini-mental state examination at a week, 1, 6 and 12 months after procedure.
SF-12 at 1, 6 and 12 months after procedure.
NYHA classification at a week, 1, 6 and 12 months after procedure.
Katz index of ADL at a week, 1, 6 and 12 months after procedure.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

75 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Age 75 years or older, undergoing TAVI or SAVR with or without concomitant revascularization at Tokushima Red Cross Hospital.

Key exclusion criteria

Need for emergency surgery, clinical instability, concomitant replacement or repair of another heart valve or the aorta, difficult to undergoing physical or psychological function test, informed consent was not obtained.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Koji Takase

Organization

Tokushima Red Cross Hospital

Division name

Department of Rehabilitation

Zip code


Address

Irinokuchi 103-banchi, Komatsushima Town, Komatsushima City, Tokushima Pref, 773-8502, Japan.

TEL

0885-32-2555

Email

mk_koudai@yahoo.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Koji Takase

Organization

Tokushima Red Cross Hospital

Division name

Department of Rehabilitation

Zip code


Address

Irinokuchi 103-banchi, Komatsushima Town, Komatsushima City, Tokushima Pref, 773-8502, Japan.

TEL

0885-32-2555

Homepage URL


Email

mk_koudai@yahoo.co.jp


Sponsor or person

Institute

Tokushima Red Cross Hospital

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

徳島赤十字病院


Other administrative information

Date of disclosure of the study information

2018 Year 04 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 04 Month 01 Day

Date of IRB

2018 Year 04 Month 01 Day

Anticipated trial start date

2018 Year 05 Month 21 Day

Last follow-up date

2024 Year 04 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study is a prospective, observational study.


Management information

Registered date

2018 Year 04 Month 24 Day

Last modified on

2023 Year 06 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036901


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name